Beilstein Arch. 2019, 201977. https://doi.org/10.3762/bxiv.2019.77.v1
Published 26 Jul 2019
Hexagonal boron nitrides (hBNs) are promising nanomaterials with their high boron content, non-toxic nature in inactive form, high chemical stability and mechanical strength. However, their hydrophobic nature limits their use in biomedical applications. Therefore, the hBNs have been functionalized with DSPE-PEG-NH2 to increase their colloidal stability and circulation time in bloodstream, as well as to provide active sites on their surface for further functionalization with tumor targeting agents. Then, further functionalization of the DSPE-PEG-hBNs with transferrin was performed for selective targeting of transferrin receptors overexpressed by brain tumor cells. Then, the cellular interaction and biocompatibility of the structure was investigated on glioblastoma multiform (U87MG) cancer cells. The cellular investigations showed that transferrin functionalization of the DSPE-PEG-hBNs increased their uptake by glioblastoma cancer cells, and decreased cell viability due to the enhanced cellular internalization. Based on the data, the TrF-DSPE-PEG-hBNs are promising agents to evaluate them as drug carrying and targeting applications.
Keywords: cytotoxicity, drug delivery, DSPE-PEG, hexagonal boron nitride, transferrin
When a peer-reviewed version of this preprint is available, this information will be updated in the information box above. If no peer-reviewed version is available, please cite this preprint using the following information:
Emanet, M.; Şen, Ö.; Culha, M. Beilstein Arch. 2019, 201977. doi:10.3762/bxiv.2019.77.v1
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and
Zotero.
© 2019 Emanet et al.; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0). Please note that the reuse, redistribution and reproduction in particular requires that the authors and source are credited.
The license is subject to the Beilstein Archives terms and conditions: (https://www.beilstein-archives.org/xiv/terms)